In cancer patients with colorectal cancer (n = 5), liver cancer (n = 3), lung cancer (n = 3), and gastric cancer (n = 7), FCS indicated that ULBP3 expression was much higher in the tumor tissue than in the adjacent non-tumor tissue (ANTT). The gene discussed is ULBP3; the disease is liver cancer.